# EDGAR Filing Document

**Accession Number:** 0000875186
**File Stem:** 0000950130-26-000048
**Filing Date:** 2026-1
**Character Count:** 24929
**Document Hash:** 3b09c78bcd0ce72af1602692ac2f8819
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950130-26-000048.hdr.sgml**: 20260106

**ACCESSION NUMBER**: 0000950130-26-000048

**CONFORMED SUBMISSION TYPE**: 497K

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20260106

**DATE AS OF CHANGE**: 20260106

**EFFECTIVENESS DATE**: 20260106

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MORGAN STANLEY PATHWAY FUNDS
- **CENTRAL INDEX KEY:** 0000875186

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **FISCAL YEAR END:** 0831

**FILING VALUES:**
- **FORM TYPE:** 497K
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 033-40823
- **FILM NUMBER:** 26511174

**BUSINESS ADDRESS:**
- **STREET 1:** 2000 WESTCHESTER AVENUE
- **CITY:** PURCHASE
- **STATE:** NY
- **ZIP:** 10577
- **BUSINESS PHONE:** 8883749999

**MAIL ADDRESS:**
- **STREET 1:** 2000 WESTCHESTER AVENUE
- **CITY:** PURCHASE
- **STATE:** NY
- **ZIP:** 10577

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CONSULTING GROUP CAPITAL MARKETS FUNDS
- **DATE OF NAME CHANGE:** 19950125

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** TRUST FOR TRAK INVESTMENTS
- **DATE OF NAME CHANGE:** 19920929

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** INSTITUTIONAL ADVISORS PORTFOLIOS
- **DATE OF NAME CHANGE:** 19600201

## Series and Classes Contracts Data

### Inflation-Linked Fixed Income Fund (Series ID: S000052236)

| Class ID   | Class Name                         | Ticker Symbol   |
|:---|:---|:---|
| C000164312 | Inflation-Linked Fixed Income Fund | TILUX           |

![LOGO](g84000g84a00.jpg)

**January 1, 2026** 

*Summary Prospectus* 

Before you invest, you may want to review the Fund's prospectus, which contains more information about the Fund and its risks. The Fund's prospectus, dated January 1, 2026, and Statement of Additional Information, dated January 1, 2026 are incorporated by reference into the summary prospectus, making them legally part of the summary prospectus. You can find the Fund's prospectus and other information about the Fund online at www.morganstanley.com/wealth-investmentsolutions/cgcm. You can also get this information at no cost by calling 1-800-869-3326 or by sending an e-mail request to client.field.services@morganstanley.com.

------

**Investment objective** 

Total return that exceeds the rate of inflation over an economic cycle.

**Fund fees and expenses** 

This table describes the fees and expenses you may pay if you buy and hold shares of the Fund.

**Annual Advisory Program Fees** 

(fees paid directly from your investment in the applicable Morgan Stanley-sponsored investment advisory program)

---

| | |
|:---|:---|
| &nbsp;&nbsp; Maximum annual fees in the Consulting Group Advisor, Select UMA or Portfolio Management investment advisory programs (as a percentage of prior quarter-end net assets)\* | 2.00% |

---

**Annual Fund Operating Expenses** 

(expenses that you pay each year as a percentage of the value of your investment in the Fund)

---

| | |
|:---|:---|
|  Management Fees\* | 0.50% |
|  Distribution (12b-1) Fees |  |
|  Other Expenses<sup>(1)</sup> | 1.82% |
|  Total Annual Fund Operating Expenses | 2.32% |
|  Waiver\* | (0.05)% |
|  Net Annual Fund Operating Expenses\*<sup>(1)</sup> | 2.27% |

---

\* CGAS (defined herein) has contractually agreed to waive fees and reimburse expenses in order to keep the Fund's management fees from exceeding the total amount of sub-advisory fees paid by CGAS plus 0.20% based on average net assets. This contractual waiver will only apply if the Fund's total management fees exceed the total amount of sub-advisory fees paid by CGAS plus 0.20% and will not affect the Fund's total management fees if they are less than such amount. This fee waiver and/or reimbursement will continue for at least one year from the date of this prospectus or until such time as the Board of Trustees acts to discontinue all or a portion of such waiver and/or reimbursement when they deem such action is appropriate.

<sup>(1)</sup> Includes interest expense which represents 1.51%.

**Examples** 

These examples are intended to help you compare the cost of investing in the Fund with the cost of investing in other mutual funds. The examples assume that you invest $10,000 in the Fund for the time periods indicated. The examples also assume that your investment has a 5% return each year and that the Fund's operating expenses remain the same. The effect of the Fund's contractual fee waiver is only reflected in the first year of the example. The figures are calculated based upon total annual Fund operating expenses and a maximum annual fee of 2.00% for the applicable Morgan Stanley-sponsored investment advisory program through which you invest. Although your actual costs may be higher or lower, based on these assumptions your costs would be:

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; **AFTER**<br> **1 YEAR** | **AFTER<br>3 YEARS** | **AFTER<br>5 YEARS** | **AFTER<br>10 YEARS** |
| $429 | $1305 | $2193 | $4467 |

---

**Portfolio turnover** 

The Fund pays transaction costs, such as commissions, when it buys and sells securities (or "turns over" its portfolio). A higher portfolio turnover rate may indicate higher transaction costs and may result in higher taxes when Fund shares are held in a taxable account. These costs, which are not reflected in annual fund operating expenses or in the above examples, affect the Fund's performance. During the fiscal year ended August 31, 2025, the Fund's portfolio turnover rate was 112% of the average value of its portfolio.

**Principal investment strategies** 

Under normal market conditions, the Fund will invest at least 80% of its net assets (plus the amount of any borrowing for investment purposes) in fixed income securities. The Fund seeks to allocate assets among investments to achieve the highest level of real return (total return less the rate of inflation). The Fund will shift its investments among the following general asset classes: inflation-indexed securities issued by governments, corporations, and municipal issuers; investment grade fixed income securities and high-yield fixed income securities (i.e., junk bonds) issued by governments, corporations, and municipal issuers; and short-term non-dollar denominated debt securities. The Fund may also, to a lesser extent, invest in equity securities with high correlation to broad measures of inflation.

Inflation-indexed securities are fixed income securities that are structured to provide protection against inflation. The value of the security's principal or the interest income paid on the security will be adjusted to track changes in an official inflation measure. The U.S. Treasury uses the Consumer Price Index for Urban Consumers as their inflation measure. Inflation-indexed securities issued by a foreign government are generally adjusted to reflect a comparable inflation index, calculated by that government.

The Fund invests primarily in investment grade debt securities; however, the Fund may invest up to 20% of its total assets in below investment grade debt securities (i.e., junk bonds), as rated by Moody's, S&P or Fitch or, if unrated, determined by the Sub-adviser (as defined below) to be of comparable credit quality to such a rating. The Fund may also invest up to 30% of its total assets in foreign currency denominated securities, including emerging market securities. For purposes of pursuing its investment goal, the Fund may enter into currency-related transactions involving certain derivative instruments, including currency and cross currency forward contracts. The use of derivative currency transactions may allow the Fund to reduce a specific risk exposure of a portfolio security or its denominated currency or to obtain net long exposure to selected currencies. Under normal market conditions, the Fund will seek to limit its foreign currency exposure to 20% of its total assets.

The Fund may invest, without limitation, in derivative instruments, such as options, futures contracts, or swap agreements, or in mortgage- or asset- backed securities, subject to applicable law and any other restrictions described

---

| | |
|:---|:---|
| **2** | **MORGAN STANLEY \| 2026** |

---

------

in this Prospectus or Statement of Additional Information. The Fund may purchase or sell securities on a when-issued, delayed delivery, or forward commitment basis and may engage in short sales. The Fund may, without limitation, seek to obtain market exposure to the securities in which it primarily invests by entering into a series of purchase and sale contracts or by using other investment techniques (such as buy backs or dollar rolls). The Fund may also invest up to 10% of its total assets in preferred stocks.

The Fund's investment objective is not fundamental and may be changed by the Board of Trustees without shareholder approval.

**Principal risks of investing in the Fund** 

Loss of money is a risk of investing in the Fund.

The Fund's principal risks include:

• *Interest Rate Risk,* the risk that fixed income securities will decline in value because of an increase in interest rates; a fund with longer average portfolio duration will be more sensitive to changes in
interest rates than a fund with shorter average portfolio duration.

• *Call Risk,* the risk that an issuer may exercise its right to redeem a fixed income security earlier than expected (a call). Issuers may call outstanding securities prior to their maturity for a number of reasons
(e.g., declining interest rates, changes in credit spreads and improvements in the issuer's credit quality). If an issuer calls a security that the Fund has invested in, the Fund may not recoup the full amount of its initial investment and may
be forced to reinvest in lower-yielding securities, securities with greater credit risks or securities with other, less favorable features.

• *Credit Risk,* the risk that the Fund could lose money if the issuer or guarantor of a fixed income security, or the counterparty to a derivative contract, is unable or unwilling to meet its financial
obligations.

• *High Yield Risk,* the risk that high yield securities and unrated securities of similar credit quality (commonly known as "junk bonds") are subject to greater levels of credit, call and liquidity
risks. High yield securities are considered primarily speculative with respect to the issuer's continuing ability to make principal and interest payments and may be more volatile than higher-rated securities of similar maturity.

• *Market Risk,* the risk that the value of securities owned by the Fund may go up or down, sometimes rapidly or unpredictably, due to factors affecting securities markets generally or particular industries.
Environmental and public health risks, such as natural disasters, epidemics, pandemics or widespread fear that such events may occur, may impact markets adversely and cause market volatility in both the short- and long-term.

• *Issuer Risk,* the risk that the value of a security may decline for a reason directly related to the issuer, such as management performance, financial leverage and reduced demand for the
issuer's goods or services.

• *Liquidity Risk,* the risk that a particular investment may be difficult to purchase or sell and that the Fund may be unable to sell illiquid securities at an advantageous time or price or achieve its desired
level of exposure to a certain sector.

Liquidity risk may result from the lack of an active market, reduced number and capacity of traditional market participants to make a market in fixed income securities, and may be magnified in a rising interest rate environment or other circumstances where investor redemptions from fixed income mutual funds may be higher than normal, causing increased supply in the market due to selling activity. <br>

• *Derivatives Risk,* the risk of investing in derivative instruments (such as forwards, futures, options, swaps and structured securities), include liquidity, interest rate, market, and credit risks, each of
which is described herein. Derivative instruments also may be difficult to accurately price due to their complexity, particularly derivative instruments that are traded off an exchange (also known as "over the counter"). Changes in the
value of the derivative may not correlate perfectly with, and may be more sensitive to market events than, the underlying asset, rate or index, and the Fund could lose more than the initial amount invested. The Fund's use of derivatives may
result in losses to the Fund, a reduction in the Fund's returns and/or increased volatility. Over-the-counter derivatives are also subject to the risk that the other party in the transaction will not fulfill its contractual obligations. For
derivatives traded on exchanges, the primary credit risk is the creditworthiness of the Fund's clearing broker or the exchange itself.

• *LIBOR Transition Risk* refers to the fact that the elimination of the London Inter-Bank Offered Rate ("LIBOR") rate may adversely affect the interest rates on, and value of, certain Fund investments
that are tied to LIBOR. The U.K. Financial Conduct Authority ceased publishing all LIBOR settings on a representative basis after June 30, 2023. Some LIBOR rates continued to be published, but only on a temporary, synthetic, and
non-representative basis. These temporary, synthetic LIBOR rates were discontinued in September 2024. Alternatives to LIBOR are established or in development in most major currencies and markets are slowly responding to these new rates. It is
difficult to predict the full impact of the transition away from LIBOR on the Fund.

• *Equity Risk,* the risk that the value of equity securities, such as common stocks and preferred stocks, may decline due to general market conditions which are not specifically related to a particular company
or to factors affecting a particular industry or industries. Equity securities generally have greater price volatility than fixed income securities.

• *Mortgage-Related and Other Asset-Backed Securities risk,* the risks of investing in mortgage-related and other asset-backed securities, including interest rate risk, extension risk, prepayment risk, and
credit risk.

• *Asset-Backed Securities Risk*, exists when the Fund invests in asset-backed securities which are structured like mortgage-backed securities, but instead of mortgage loans or interests in mortgage loans, the
underlying assets may include such items as motor vehicle installment sales or installment loan contracts, leases of various types of real and personal property, and receivables from credit card agreements. Asset-backed securities are subject to
many of the same risks as mortgage-backed securities including prepayment and extension risk. The ability of an issuer of asset-backed securities to enforce its security interest in the underlying assets may be limited.

---

| | |
|:---|:---|
| **3** | **MORGAN STANLEY \| 2026** |

---

------

• *Foreign (Non-U.S.) Investment Risk,* the risk that investing in foreign securities may result in the Fund experiencing more rapid and extreme changes in value than a fund that invests exclusively in
securities of U.S. companies, due to smaller markets, differing reporting, accounting and auditing standards, increased risk of delayed settlement of portfolio transactions or loss of certificates of portfolio securities, and the risk of
unfavorable foreign government actions, including nationalization, expropriation or confiscatory taxation, currency blockage, or political changes or diplomatic developments. Foreign securities may also be less liquid and more difficult to value
than securities of U.S. issuers.

• *Emerging Markets Risk,* the risk of investing in emerging market securities, primarily increased foreign investment risk.

• *Sovereign Debt Risk,* the risk that investments in fixed income instruments issued by sovereign entities may decline in value as a result of default or other adverse credit event resulting from the
issuer's inability or unwillingness to make principal or interest payments in a timely fashion.

• *Currency Risk,* the risk that foreign currencies will decline in value relative to the U.S. dollar and affect the Fund's investments in foreign currencies or in securities that trade in, and receive
revenues in, or in derivatives that provide exposure to, foreign currencies.

• *Leveraging Risk,* the risk that certain transactions of the Fund, such as reverse repurchase agreements, loans of portfolio securities, and the use of when-issued, delayed delivery or forward commitment
transactions, or derivative instruments, may give rise to leverage, magnifying gains and losses and causing the Fund to be more volatile than if it had not been leveraged. This means that leverage entails a heightened risk of loss.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

• *Short Sale Risk,* the risk of entering into short sales, including the potential loss of more money than the actual cost of the investment, and the risk that the third party to the short sale may fail to
honor its contract terms, causing a loss to the Fund.

• *Portfolio Turnover Risk,* which is the risk that due to its investment strategy, the Fund may buy and sell securities frequently. This may result in higher transaction costs and additional capital gains tax
liabilities.

An investment in the Fund is not a deposit of a bank and is not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency. For more information on the risks of investing in the Fund please see the ***Fund details*** section of the Fund's Prospectus.

**Performance** 

The bar chart below shows how the Fund's investment results have varied from year to year, and the following table shows how the Fund's annual total returns for various periods compare to those of the Fund's broad-based index and an additional index. This information provides some indication of the risks of investing in the Fund. The Fund is available only to investors participating in Morgan Stanley-sponsored investment advisory programs. These programs charge an annual fee (see Annual Advisory Program Fees above). **The performance information in the bar chart and table below does not reflect this fee, which would reduce your return.** The Fund's past performance, before and after taxes, does not necessarily indicate how the Fund will perform in the future. For current performance information please see www.morganstanley.com/wealth-investmentsolutions/cgcm.

**Annual total returns (%) calendar years** 

**Inflation-Linked Fixed Income Fund**![LOGO](g84000g14g14.jpg)

**Fund's best and worst calendar quarters** 

Best: 6.18% 2nd quarter 2020

Worst: (6.42)% 2nd quarter 2022

Year-to-date: 7.51% (through 3rd quarter 2025)

---

| | |
|:---|:---|
| **4** | **MORGAN STANLEY \| 2026** |

---

------

**Average Annual Total Returns** 

(for the periods ended December 31, 2024)

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; **INCEPTION DATE: 3/8/2016** | **1 YEAR** | **5 YEAR** | **SINCE<br>INCEPTION** |
| &nbsp;&nbsp; **Fund (without advisory program fee)** | &nbsp;&nbsp; **Fund (without advisory program fee)** | &nbsp;&nbsp; **Fund (without advisory program fee)** |  |
| &nbsp;&nbsp; Return Before Taxes | 1.86% | 1.90% | 2.45% |
| &nbsp;&nbsp; Return After Taxes on<br> Distributions | 0.34% | (0.47)% | 0.57% |
| &nbsp;&nbsp; Return After Taxes on<br> Distributions and Sale of Fund Shares | 1.09% | 0.71% | 1.16% |
| &nbsp;&nbsp; Bloomberg U.S. Aggregate Bond Index (reflects no deduction for fees, expenses or taxes) | 1.25% | (0.33)% | 1.23% |
| &nbsp;&nbsp; Bloomberg U.S. Treasury Inflation Protected Securities (TIPS) Index (reflects no deduction for fees, expenses or taxes) | 1.84% | 1.87% | 2.49% |

---

The after-tax returns are calculated using the highest historical individual federal marginal income tax rates and do not reflect the impact of state and local taxes. Actual after-tax returns depend on an individual investor's tax situation and may differ from those shown, and after-tax returns shown are not relevant to investors who hold their Fund shares through tax-deferred arrangements, such as 401(k) plans or individual retirement accounts. In some cases, the return after taxes may exceed the return before taxes due to an assumed tax benefit from any losses on a sale of Fund shares at the end of the measurement period.

The Fund's broad-based securities market index is the Bloomberg U.S. Aggregate Bond Index, which is composed of debt securities of the U.S. government and its agencies and publicly issued, fixed rate, non-convertible, investment-grade domestic corporate debt with at least one year remaining to maturity. The Fund also compares its performance to the Bloomberg U.S. Treasury Inflation Protected Securities (TIPS) Index. Unlike the Fund, the benchmarks are unmanaged and do not include any fees or expenses. An investor cannot invest directly in an index.

**Investment adviser** 

Consulting Group Advisory Services LLC ("CGAS" or the "Manager"), a business of Morgan Stanley Wealth Management ("MSWM"), serves as the investment adviser for the Fund. Subject to Board review, the Manager selects and oversees professional money managers (each a "Sub-adviser," collectively, the "Sub-advisers") who are responsible for investing the assets of the Fund. The Sub-advisers are selected based primarily upon the research and recommendation of the Manager, which includes a quantitative and qualitative evaluation of a Sub-adviser's skills and investment results in managing assets for specific asset classes, investment styles and strategies. The Manager allocates and, when appropriate, reallocates the Fund's assets among one or more Sub-advisers, continuously monitors and

evaluates Sub-adviser performance (including trade execution), performs other due diligence functions (such as an assessment of changes in personnel or other developments at the Sub-advisers), and oversees Sub-adviser compliance with the Fund's investment objectives, policies and guidelines. The Manager also monitors changes in market conditions and considers whether changes in the allocation of Fund assets or the lineup of Sub-advisers should be made in response to such changes in market conditions. Sub-advisers may also periodically recommend changes or enhancements to the Fund's investment objectives, policies and guidelines, which are subject to the approval of the Manager and may also be subject to the approval of the Board.

---

| | |
|:---|:---|
| **5** | **MORGAN STANLEY \| 2026** |

---

------

**Sub-adviser and portfolio managers** 

Pacific Investment Management Company LLC ("PIMCO")

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; **PORTFOLIO MANAGERS** | **SUB-ADVISER OR ADVISER** | **FUND'S PORTFOLIO** <br> **MANAGER SINCE**  |
| &nbsp;&nbsp; Daniel He, Executive Vice President and Portfolio Manager | PIMCO | 2019 |
| &nbsp;&nbsp; Lorenzo Pagani, Managing Director and Portfolio Manager | PIMCO | 2025 |

---

**Purchase and sale of Fund shares** 

Purchases of shares of the Fund must be made through an investment advisory program with Morgan Stanley. You may purchase or sell shares of the Fund at net asset value on any day the New York Stock Exchange ("NYSE") is open by contacting your Morgan Stanley Financial Advisor.

• The minimum initial aggregate investment in the Morgan Stanley-sponsored investment advisory programs is $1,000.

• There is no minimum on additional investments in the Fund or the applicable investment advisory program through which you invest.

• Each of the Fund and the Morgan Stanley-sponsored investment advisory programs through which investments in the Fund are offered may vary or waive these investment minimums at any time.

For more information about the Morgan Stanley-sponsored investment advisory programs, see the About the Funds section of this Prospectus.

**Tax information** 

The Fund's distributions are generally taxable to you as ordinary income, capital gains, or a combination of the two.

**Payments to financial intermediaries** 

If you purchase shares of the Fund through a broker-dealer or other financial intermediary (such as a bank), the Fund and its related companies may pay the intermediary for the sale of Fund shares and related services. These payments may create a conflict of interest by influencing the broker-dealer or other intermediary and your sales person to recommend the Fund over another investment. Ask your salesperson or visit your financial intermediary's website for more information.

---

| | |
|:---|:---|
| **6** | **MORGAN STANLEY \| 2026** |

---

------

[This Page Intentionally Left Blank]

---

| | |
|:---|:---|
| **7** | **MORGAN STANLEY \| 2026** |

---

------

<sup>®</sup>2024 Morgan Stanley. Member SIPC CS-1 1/26